Home > Nikkei rises 2.5 percent in expectation of early development of COVID-19 vaccine

Business
Nikkei rises 2.5 percent in expectation of early development of COVID-19 vaccine

Description

Tokyo (Stock Exchange), Nov 24 (EFE / EPA).- The Tokyo stock benchmark soared 638.22 points or 2.5 percent to close at 26,165.59 in expectation of early development of vaccine for the COVID-19 coronavirus. (Camera: KIMIMASA MAYAMA)SHOT LIST: A DISPLAY SHOWING CLOSING INFORMATION OF THE NIKKEI STOCK AVERAGE IN TOKYO, JAPAN.

Added on the 24/11/2020 13:00:00 - Copyright : EFE Inglés

To customise your video :

Or Create an account

More videos on the subject

More videosBusiness

Watch video of The Post-Brexit Recovery Across European Markets Has Stalled With Major Share Indexes Mixed And Safe-haven Demand For Precious Metals Helping The Price Of Silver Surge To A Near-two Year High.  But,  As Sonia Legg Reports, Trading Volumes Were Light Becasue Of The July 4 Public Holiday In The United States. - European shares end post-Brexit rally - Label : Reuters EN -
Business

European shares end post-Brexit rally

04/07/2016 15:56:29